Further to intimation dated February 10, 2023, on the Inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facility Unit–2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh from 6th February, 2023 to 10th February, 2023, Laurus Labs has informed that the Company has received the Establishment Inspection Report (EIR) from USFDA.
The above information is a part of company’s filings submitted to BSE.